Aristea Grammoustianou, PhD, leads Biosensors at Impli, focusing on innovation in biosensing and diagnostics. With over a decade of experience translating advanced sensing technologies from the lab to real-world applications, she has driven the development of wearable and point-of-care platforms delivering clinically relevant results. Before joining Impli, Aristea co-invented proprietary biosensor technologies, contributed to patent filings, and advanced diagnostic prototypes through rigorous validation in EU-funded research programs recognized by the European Commission. She holds a PhD in Medical Biotechnology and is the author of 9 peer-reviewed publications. Aristea is dedicated to transforming biosensing innovation into scalable healthcare solutions, with a special emphasis on women's health and fertility care.